Navigation Links
Study targets treatment for serious ACE inhibitor side effect
Date:4/28/2011

DETROIT A new Henry Ford Hospital study takes a closer look at one of the lesser known, but potential most serious side-effects of ACE inhibitor use facial, tongue and airway swelling and identifies a successful and less invasive course of treatment.

Using a treatment protocol developed by Henry Ford, patients' symptoms were quickly diagnosed and promptly treated to reduce swelling, resulting in no tracheotomies to open the airway or reported deaths, says study author Samer Al-Khudari, M.D.

"This side-effect is rare, but when it happens, it can be anxiety-provoking for both patients and physicians," says Dr. Al-Khudari, a member of the Department of Otolaryngology-Head & Neck Surgery at Henry Ford.

"Our goal was to really take a closer look at the treatment options available and develop a better standard of care for not just otolaryngologist, but all health care providers to follow."

The study will presented April 30 at 114th Annual Meeting of the Triological Society, part of the Combined Otolaryngology Spring Meetings in Chicago.

ACE inhibitors are a popular class of drugs most often prescribed to treat high blood pressure, congestive heart failure and kidney disease, as well as prevent stroke.

While they are well-tolerated by most patients, there are some side effects including angiodema, swelling that occurs in areas of the head and neck (floor of mouth, tongue, lips, throat) and can lead to airway obstruction.

Patients most commonly come into the emergency department experiencing difficulty swallowing, shortness of breath and voice changes.

ACE inhibitor induced angiodema (AIIA) tends to be more common among African Americans.

The study included 40 patients who received care at Henry Ford Hospital over a one-year period. The majority of patients (92%) were African American, and most were taking an ACE inhibitor called Lisinopril.

Treatment for all patients at Henry Ford included IV corticosteroids and antihistamines. On average, medical therapy was initiated by otolaryngology services about one hour after the initial evaluation in the emergency department.

All patients underwent a physical examination and laryngoscopy, which uses a flexible viewing tube to evaluate the back of the throat, including the voice box. Floor of mouth swelling was present in 50% of patients, and massive tongue swelling was found in 11.6%.

About half of the patients were admitted to the intensive care unit, while six required intubation and 14 were monitored and discharged from the ER. None of the patients needed emergency tracheotomy or cricothyrotomy for airway control.

Throughout the course of treatment, inpatients were evaluated at least twice a day by the otolaryngology service, and repeat flexible laryngoscopy was performed based on symptoms. Patients were discharged with or without a tapered steroid dose and scheduled for outpatient follow-up.

For most patients, AIIA was resolved in 27 hours.

"If a patient taking an ACE inhibitor notices intermittent swelling in the mouth, lips, face, the medication may very well be the culprit. When this type of swelling occurs, we recommend that patients contact their health care providers immediately and not wait for symptoms to worsen," says Dr. Khudari.

Regardless, Dr. Khudari says it's very important for patients to note that the benefits of ACE inhibitors greatly outweigh the potential risks.


'/>"/>

Contact: Krista Hopson
khopson1@hfhs.org
313-874-7207
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. JAMA study reports on fatty liver disease in children and teens
2. Armadillos Give Leprosy to Humans in Southern U.S.: Study
3. Study Highlights Arthritis Toll on Quality of Life
4. Morning Heart Attacks Cause More Damage, Study Finds
5. Higher Oxygen Levels Improve Preemie Survival: Study
6. Baycrest and NHL Alumni partner on brain health study
7. Removing Ovaries During Hysterectomy Wont Raise Other Health Risks: Study
8. University of Houston wins NIH grant for vaccine study
9. When Docs Own MRIs, Back Pain Scans Increase: Study
10. Evidence-Based Heart Attack Care Reduces Deaths: Study
11. Study: Resiniferatoxin may increase sepsis-related mortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve ... Desert, is opening a new office in San Clemente, California this month. Achieve ... in Southern California, successfully treating individuals struggling with major depression. Depression impacts over ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... – will lecture to primary eye care practitioners on the latest breakthroughs in ... upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Wettstein Agencies, a Denver ... business professionals throughout central Colorado, is joining local nonprofit Aurora Warms The Night ... The Night organization is committed to breaking the cycle of homelessness and poverty ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians Education Review®, LCC (PER®) ... speaker for the 34th Annual Miami Breast Cancer Conference®, on March 9-12, 2017 ... Phil Talamo, said, “We are delighted to have Sandra Lee join us as ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, FloSports , a ... announced a new agreement as part of a long-term extension of their media partnership. ... the airing of some of the sport’s premier events exclusively on FloWrestling.com as well ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... Jan. 17, 2017 Following an initial ... praised the Food and Drug Administration,s (FDA,s) final ... Drug Products by Pharmacies and Outsourcing Facilities." In ... limitation on pre-packaging -- which would have put ... to long term care (LTC) pharmacies.  ...
(Date:1/17/2017)... ReportsnReports.com adds "Anaphylaxis - Pipeline Review, H2 2016" ... Anaphylaxis,s therapeutic pipeline with comprehensive information on the therapeutic development ... assessment by drug target, mechanism of action (MoA), route of ... featured news and press releases. ... Complete report on H2 2016 pipeline ...
Breaking Medicine Technology: